Copyright
©The Author(s) 2016.
World J Gastroenterol. Oct 21, 2016; 22(39): 8798-8805
Published online Oct 21, 2016. doi: 10.3748/wjg.v22.i39.8798
Published online Oct 21, 2016. doi: 10.3748/wjg.v22.i39.8798
Table 2 Multivariable analysis to identify predictors of overall survival in 116 hepatocellular carcinoma patients
| Factors | Hazard ratio | 95%CI | P value |
| AFP ≥ 400 ng/mL | 1.691 | 1.094-2.614 | 0.018 |
| Incomplete tumor capsule | 0.979 | 0.659-1.454 | 0.915 |
| Tumor size ≥ 5 cm | 1.582 | 1.027-2.438 | 0.038 |
| Edmondson grade III–IV | 1.149 | 0.663-1.992 | 0.621 |
| EP1 receptor expression | 2.318 | 1.190-4.516 | 0.014 |
- Citation: Yang HJ, Jiang JH, Yang YT, Yang XD, Guo Z, Qi YP, Zeng FH, Zhang KL, Chen NZ, Xiang BD, Li LQ. Cyclooxygenase-2 expression is associated with initiation of hepatocellular carcinoma, while prostaglandin receptor-1 expression predicts survival. World J Gastroenterol 2016; 22(39): 8798-8805
- URL: https://www.wjgnet.com/1007-9327/full/v22/i39/8798.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i39.8798